Feedback. SCENAR helped to defeat Myasthenia Gravis
Aneeshia Khoja, SCENAR therapist and official distributor of RITM OKB ZAO in The Republic of South Africa, has received very positive feedback from the patient's daughter, who brought her mother to get the treatment. Please see the feedback and pictures below.
SCENAR trademark certificate is obtained in Israel!
The SCENAR trademark is now registered in the Israeli trademark register under two classes: class 10 and class 44. The certificate is valid until September 13th, 2028.
Latin America is the first to learn the new SCENAR treatment protocols!
RITM OKB ZAO was again visited by a delegation from Latin America. Doctors, physiotherapists, and masseurs from several countries were learning and practicing the new SCENAR technologies developed in RITM OKB. The lecturer for this training was Boris Kulizskiy.
SCENAR Vertebra is now certified!
SCENAR Vertebra is now officially certified to be marketed in Australia. The document was issued by TGA to RITM Australia Pty Ltd. which is an affiliated company of RITM OKB ZAO and a partner of TRONITEK LLC. Previously SCENAR Vertebra was approved for the EU market by issuing the CE certificate. The first mutually developed device named SCENAR Vertebra entered the European market at the end of 2018.
The operationg modes with biocontrolled feedback are now patented in the United States!
The patent application No. 15778519 "METHOD OF ADAPTIVE ELECTRIC ACTION ON A LIVING ORGANISM (VARIANTS)" (authors Y.Z. Grinberg, Y.Y. Starovoytov, M.A. Unakafov) has received a positive decision! That ensures the protection of the Russian patent No.2645923 from December 1st, 2015, in the United States.